Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 5 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 4 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 16 hours agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via AOL· 4 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 4 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Wichita Eagle via Yahoo News· 4 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 4 days agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 17 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...